{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:32:30Z","timestamp":1791322350581,"version":"4.3.1"},"reference-count":264,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.autrev.2017.05.015","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T00:00:34Z","timestamp":1496188834000},"page":"856-874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Autophagy in neuroinflammatory diseases"],"prefix":"10.1016","volume":"16","author":[{"given":"Sylviane","family":"Muller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Brun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Ren\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"de S\u00e8ze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Loeffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Jeltsch-David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2017.05.015_bb0005","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","article-title":"Autophagy: renovation of cells and tissues","volume":"147","author":"Mizushima","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2017.05.015_bb0010","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.molimm.2014.02.008","article-title":"Autophagy, a new determinant of plasma cell differentiation and antibody responses","volume":"62","author":"Cenci","year":"2014","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0015","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/ni.3003","article-title":"Chaperone-mediated autophagy regulates T cell responses through targeted degradation of negative regulators of T cell activation","volume":"15","author":"Valdor","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0020","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4161\/auto.7.7.14733","article-title":"Microautophagy in mammalian cells: revisiting a 40-year-old conundrum","volume":"7","author":"Mijaljica","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.autrev.2017.05.015_bb0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/cr.2013.153","article-title":"Chaperone-mediated autophagy: roles in disease and aging","volume":"24","author":"Cuervo","year":"2014","journal-title":"Cell Res"},{"key":"10.1016\/j.autrev.2017.05.015_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2014.117","article-title":"Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies","volume":"47","author":"Ciechanover","year":"2015","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.autrev.2017.05.015_bb0035","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2010.08.004","article-title":"Identification of regulators of chaperone-mediated autophagy","volume":"39","author":"Bandyopadhyay","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.autrev.2017.05.015_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)","volume":"12","author":"Klionsky","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.autrev.2017.05.015_bb0045","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1534-5807(03)00296-X","article-title":"A unified nomenclature for yeast autophagy-related genes","volume":"5","author":"Klionsky","year":"2003","journal-title":"Dev Cell"},{"key":"10.1016\/j.autrev.2017.05.015_bb0050","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/45257","article-title":"Induction of autophagy and inhibition of tumorigenesis by beclin 1","volume":"402","author":"Liang","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2017.05.015_bb0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/cr.2013.161","article-title":"Autophagy and human diseases","volume":"24","author":"Jiang","year":"2014","journal-title":"Cell Res"},{"key":"10.1016\/j.autrev.2017.05.015_bb0060","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.tips.2014.09.002","article-title":"Targeting autophagy in neurodegenerative diseases","volume":"35","author":"Vidal","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.autrev.2017.05.015_bb0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1172\/JCI73938","article-title":"Development of autophagy inducers in clinical medicine","volume":"125","author":"Levine","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2017.05.015_bb0070","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/dna.2014.2765","article-title":"Autophagy and ubiquitination in cardiovascular diseases","volume":"34","author":"Martins-Marques","year":"2015","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0075","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.arr.2016.02.009","article-title":"Lysosomal cell death mechanisms in aging","volume":"32","author":"G\u00f3mez-Sintes","year":"2016","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.autrev.2017.05.015_bb0080","series-title":"Autophagy networks in inflammation","first-page":"203","article-title":"Role of autophagy in brain sculpture: physiological and pathological implications","author":"Nobili","year":"2016"},{"key":"10.1016\/j.autrev.2017.05.015_bb0085","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/215657a0","article-title":"\u201cPhagocytic\u201d lysosomes in chromatolytic neurones","volume":"215","author":"Dixon","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2017.05.015_bb0090","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnen\/64.2.113","article-title":"Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study","volume":"64","author":"Nixon","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0095","first-page":"25","article-title":"Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease","volume":"12","author":"Anglade","year":"1997","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0100","first-page":"240","article-title":"Electron microscope and enzyme studies in cerebral biopsies of Huntington's chorea","volume":"99","author":"Roizin","year":"1974","journal-title":"Trans Am Neurol Assoc"},{"key":"10.1016\/j.autrev.2017.05.015_bb0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1083\/jcb.200907109","article-title":"Autophagy promotes synapse development in Drosophila","volume":"187","author":"Shen","year":"2009","journal-title":"J Cell Biol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0110","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1523\/JNEUROSCI.3848-08.2009","article-title":"Unc-51 controls active zone density and protein composition by downregulating ERK signaling","volume":"29","author":"Wairkar","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2017.05.015_bb0115","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature04724","article-title":"Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice","volume":"441","author":"Hara","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2017.05.015_bb0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000008067","article-title":"Decreased regional cerebral metabolic rate for glucose in systemic lupus erythematosus patients with psychiatric symptoms","volume":"42","author":"Komatsu","year":"1999","journal-title":"Eur Neurol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pneurobio.2012.01.003","article-title":"The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim?","volume":"96","author":"Dennissen","year":"2012","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0130","first-page":"128","article-title":"Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease","volume":"2011","author":"Hegde","year":"1809","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.autrev.2017.05.015_bb0135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrneurol.2011.200","article-title":"Control of autophagy as a therapy for neurodegenerative disease","volume":"8","author":"Harris","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0140","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrn3961","article-title":"Compromised autophagy and neurodegenerative diseases","volume":"16","author":"Menzies","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.autrev.2017.05.015_bb0145","doi-asserted-by":"crossref","first-page":"11061","DOI":"10.1074\/jbc.R109.072181","article-title":"Chemical inducers of autophagy that enhance the clearance of mutant proteins in neurodegenerative diseases","volume":"285","author":"Renna","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2017.05.015_bb0150","doi-asserted-by":"crossref","DOI":"10.1111\/bph.12792","article-title":"Pharmacological regulators of autophagy and their link with modulators of lupus disease","author":"Gros","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0155","doi-asserted-by":"crossref","first-page":"139","DOI":"10.7888\/juoeh.38.139","article-title":"Natural compounds preventing neurodegenerative diseases through autophagic activation","volume":"38","author":"Huang","year":"2016","journal-title":"J UOEH"},{"key":"10.1016\/j.autrev.2017.05.015_bb0160","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.2147\/IJN.S117210","article-title":"Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier","volume":"11","author":"Vieira","year":"2016","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.autrev.2017.05.015_bb0165","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cca.2016.10.022","article-title":"TREMs in Alzheimer's disease: genetic and clinical investigations","volume":"463","author":"Cheng","year":"2016","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2017.05.015_bb0170","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.4155\/fmc-2016-0103","article-title":"Recent progress in repositioning Alzheimer's disease drugs based on a multitarget strategy","volume":"8","author":"Santos","year":"2016","journal-title":"Future Med Chem"},{"key":"10.1016\/j.autrev.2017.05.015_bb0175","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/WCO.0000000000000384","article-title":"Clinical subtypes and genetic heterogeneity: of lumping and splitting in Parkinson disease","volume":"29","author":"von Coelln","year":"2016","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0180","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40035-016-0066-0","article-title":"The study of brain functional connectivity in Parkinson's disease","volume":"5","author":"Gao","year":"2016","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.autrev.2017.05.015_bb0185","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/jnnp-2016-314601","article-title":"Neuroendocrine abnormalities in Parkinson's disease","volume":"88","author":"De Pablo-Fern\u00e1ndez","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2017.05.015_bb0190","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1503\/cmaj.151179","article-title":"An update on the diagnosis and treatment of Parkinson disease","volume":"188","author":"Rizek","year":"2016","journal-title":"CMAJ"},{"key":"10.1016\/j.autrev.2017.05.015_bb0195","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-971176","article-title":"Huntington's disease","volume":"27","author":"Walker","year":"2007","journal-title":"Semin Neurol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0200","first-page":"197","article-title":"Behavioral symptoms associated with Huntington's disease","volume":"96","author":"Anderson","year":"2005","journal-title":"Adv Neurol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0205","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1034\/j.1399-0004.2003.00093.x","article-title":"Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000","volume":"63","author":"Creighton","year":"2003","journal-title":"Clin Genet"},{"key":"10.1016\/j.autrev.2017.05.015_bb0210","first-page":"343","article-title":"Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes","volume":"57","author":"Kremer","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2017.05.015_bb0215","first-page":"16","article-title":"Phenotypic characterization of individuals with 30\u201340 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36\u201339 repeats","volume":"59","author":"Rubinsztein","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2017.05.015_bb0220","series-title":"Huntington's disease","first-page":"327","article-title":"The neuropathology of Huntington's disease","author":"Gutekunst","year":"2002"},{"key":"10.1016\/j.autrev.2017.05.015_bb0225","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","article-title":"Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin","volume":"125","author":"Graham","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2017.05.015_bb0230","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.patbio.2004.12.008","article-title":"Axonal transport failure in neurodegenerative disorders: the case of Huntington's disease","volume":"53","author":"Charrin","year":"2005","journal-title":"Pathol Biol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0235","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.patbio.2003.06.004","article-title":"Huntington's disease: how does huntingtin, an anti-apoptotic protein, become toxic?","volume":"52","author":"Rangone","year":"2004","journal-title":"Pathol Biol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0240","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainresbull.2003.12.004","article-title":"Regional and progressive changes in brain expression of complexin II in a mouse transgenic for the Huntington's disease mutation","volume":"63","author":"Freeman","year":"2004","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.autrev.2017.05.015_bb0245","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2017.05.015_bb0250","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1523\/JNEUROSCI.19-03-00964.1999","article-title":"Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition","volume":"19","author":"Kim","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2017.05.015_bb0255","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ana.410420411","article-title":"Huntingtin localization in brains of normal and Huntington's disease patients","volume":"42","author":"Sapp","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0260","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nmeth.1710","article-title":"Population-specific expression analysis (PSEA) reveals molecular changes in diseased brain","volume":"8","author":"Kuhn","year":"2011","journal-title":"Nat Methods"},{"key":"10.1016\/j.autrev.2017.05.015_bb0265","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tins.2014.09.003","article-title":"Autophagy in Huntington disease and huntingtin in autophagy","volume":"38","author":"Martin","year":"2015","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.autrev.2017.05.015_bb0270","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00439-010-0873-9","article-title":"Age at onset in Huntington's disease is modified by the autophagy pathway: implication of the V471A polymorphism in Atg7","volume":"128","author":"Metzger","year":"2010","journal-title":"Hum Genet"},{"key":"10.1016\/j.autrev.2017.05.015_bb0275","doi-asserted-by":"crossref","first-page":"14474","DOI":"10.1074\/jbc.M600364200","article-title":"Regulation of intracellular accumulation of mutant huntingtin by beclin 1","volume":"281","author":"Shibata","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2017.05.015_bb0280","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1074\/jbc.M113.536912","article-title":"Rhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy","volume":"289","author":"Mealer","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2017.05.015_bb0285","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci6030038","article-title":"Deep brain stimulation in Huntington's disease-preliminary evidence on pathophysiology, efficacy and safety","volume":"6","author":"Wojtecki","year":"2016","journal-title":"Brain Sci"},{"key":"10.1016\/j.autrev.2017.05.015_bb0295","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2017.05.015_bb0300","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1074\/jbc.M609532200","article-title":"Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein","volume":"282","author":"Sarkar","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2017.05.015_bb0305","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nchembio883","article-title":"Small molecules enhance autophagy and reduce toxicity in Huntington's disease models","volume":"3","author":"Sarkar","year":"2007","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090202","article-title":"Trehalose reverses cell malfunction in fibroblasts from normal and Huntington's disease patients caused by proteosome inhibition","volume":"9","author":"Fernandez-Estevez","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.05.015_bb0315","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1073\/pnas.1004498107","article-title":"A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model","volume":"107","author":"Tsvetkov","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2017.05.015_bb0320","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1042\/BST20130134","article-title":"Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers","volume":"41","author":"Sarkar","year":"2013","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.autrev.2017.05.015_bb0325","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12035-012-8251-3","article-title":"A\u03b2 toxicity in Alzheimer's disease","volume":"45","author":"Cavallucci","year":"2012","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0330","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1126\/science.aah6205","article-title":"Site-specific phosphorylation of tau inhibits amyloid-\u03b2 toxicity in Alzheimer's mice","volume":"354","author":"Ittner","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.autrev.2017.05.015_bb0335","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2017.05.015_bb0340","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.7638622","article-title":"Candidate gene for the chromosome 1 familial Alzheimer's disease locus","volume":"269","author":"Levy-Lahad","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.autrev.2017.05.015_bb0345","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2017.05.015_bb0350","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0355","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0360","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ni.2639","article-title":"CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation","volume":"14","author":"Sheedy","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0365","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00702-010-0433-4","article-title":"The role of microglia in amyloid clearance from the AD brain","volume":"117","author":"Lee","year":"2010","journal-title":"J Neural Transm"},{"key":"10.1016\/j.autrev.2017.05.015_bb0370","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer's disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.05.015_bb0375","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","article-title":"Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta","volume":"78","author":"Griciuc","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.autrev.2017.05.015_bb0380","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nn.3435","article-title":"CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology","volume":"16","author":"Bradshaw","year":"2013","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.autrev.2017.05.015_bb0385","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/glia.20710","article-title":"TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice","volume":"56","author":"Frank","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.autrev.2017.05.015_bb0390","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1471-4159.2009.06042.x","article-title":"A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia","volume":"109","author":"Hsieh","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.autrev.2017.05.015_bb0395","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1515\/revneuro-2014-0076","article-title":"Autophagy in Alzheimer's disease","volume":"26","author":"Zare-Shahabadi","year":"2015","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.autrev.2017.05.015_bb0400","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/ejn.12169","article-title":"Autophagy failure in Alzheimer's disease and the role of defective lysosomal acidification","volume":"37","author":"Wolfe","year":"2013","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.autrev.2017.05.015_bb0405","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuroscience.2014.01.001","article-title":"Lysosomal alkalization and dysfunction in human fibroblasts with the Alzheimer's disease-linked presenilin 1 A246E mutation can be reversed with cAMP","volume":"263","author":"Coffey","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.autrev.2017.05.015_bb0410","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.celrep.2015.07.050","article-title":"Presenilin 1 maintains lysosomal Ca(2+) homeostasis via TRPML1 by regulating vATPase-mediated lysosome acidification","volume":"12","author":"Lee","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.autrev.2017.05.015_bb0415","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1083\/jcb.200505082","article-title":"Macroautophagy\u2014a novel Beta-amyloid peptide-generating pathway activated in Alzheimer's disease","volume":"171","author":"Yu","year":"2005","journal-title":"J Cell Biol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0420","first-page":"2190","article-title":"The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice","volume":"118","author":"Pickford","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2017.05.015_bb0425","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1460-9568.2005.04279.x","article-title":"Up-regulation of lysosomal cathepsin L and autophagy during neuronal death induced by reduced serum and potassium","volume":"22","author":"Kaasik","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.autrev.2017.05.015_bb0430","doi-asserted-by":"crossref","first-page":"8924","DOI":"10.1074\/jbc.M110.180638","article-title":"Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism","volume":"286","author":"Caccamo","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2017.05.015_bb0435","first-page":"26","article-title":"Effect of trehalose on the interaction of Alzheimer's A\u03b2-peptide and anionic lipid monolayers","volume":"2011","author":"Izmitli","year":"1808","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.autrev.2017.05.015_bb0440","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.neuint.2011.01.008","article-title":"The accumulation of neurotoxic proteins, induced by proteasome inhibition, is reverted by trehalose, an enhancer of autophagy, in human neuroblastoma cells","volume":"58","author":"Casarejos","year":"2011","journal-title":"Neurochem Int"},{"key":"10.1016\/j.autrev.2017.05.015_bb0445","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4196\/kjpp.2011.15.2.107","article-title":"Suppression of autophagy and activation of glycogen synthase kinase 3beta facilitate the aggregate formation of tau","volume":"15","author":"Kim","year":"2011","journal-title":"Kor J Physiol Pharmacol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0450","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.neurobiolaging.2011.11.009","article-title":"Autophagic degradation of tau in primary neurons and its enhancement by trehalose","volume":"33","author":"Kr\u00fcger","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.autrev.2017.05.015_bb0455","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","article-title":"Molecular pathophysiology of Parkinson's disease","volume":"28","author":"Moore","year":"2005","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.autrev.2017.05.015_bb0460","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","article-title":"Neuropathology of Parkinson's disease","volume":"55","author":"Forno","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0465","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1038\/538S5a","article-title":"Diagnosis: warning signs","volume":"538","author":"Bourzac","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2017.05.015_bb0470","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson's disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.autrev.2017.05.015_bb0475","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the Parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2017.05.015_bb0480","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molcel.2015.08.016","article-title":"The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN\/NDP52 recruitment and TBK1 activation to promote mitophagy","volume":"60","author":"Heo","year":"2015","journal-title":"Mol Cell"},{"key":"10.1016\/j.autrev.2017.05.015_bb0485","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nature14893","article-title":"The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy","volume":"524","author":"Lazarou","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2017.05.015_bb0490","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/1073858415574600","article-title":"The Parkinson disease mitochondrial hypothesis: where are we at?","volume":"22","author":"Franco-Iborra","year":"2016","journal-title":"Neuroscientist"},{"issue":"Suppl. 3","key":"10.1016\/j.autrev.2017.05.015_bb0495","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson's disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0500","first-page":"693761","article-title":"Mitochondrial dysfunction: the road to alpha-synuclein oligomerization in PD","volume":"2011","author":"Esteves","year":"2011","journal-title":"Park Dis"},{"key":"10.1016\/j.autrev.2017.05.015_bb0505","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrneurol.2015.197","article-title":"Pathogenesis of Parkinson disease\u2014the gut-brain axis and environmental factors","volume":"11","author":"Klingelhoefer","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039465","article-title":"Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo","volume":"7","author":"Angot","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.05.015_bb0515","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12640-013-9420-5","article-title":"Alpha-synuclein transmission and mitochondrial toxicity in primary human foetal enteric neurons in vitro","volume":"25","author":"Braidy","year":"2014","journal-title":"Neurotox Res"},{"key":"10.1016\/j.autrev.2017.05.015_bb0520","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1096\/fj.06-6183com","article-title":"Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells","volume":"20","author":"Klegeris","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.autrev.2017.05.015_bb0525","doi-asserted-by":"crossref","first-page":"25009","DOI":"10.1074\/jbc.M300227200","article-title":"Alpha-synuclein is degraded by both autophagy and the proteasome","volume":"278","author":"Webb","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2017.05.015_bb0530","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.autrev.2017.05.015_bb0535","doi-asserted-by":"crossref","first-page":"23542","DOI":"10.1074\/jbc.M801992200","article-title":"Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells","volume":"283","author":"Vogiatzi","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2017.05.015_bb0540","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1080\/15548627.2016.1214777","article-title":"Impairment of chaperone-mediated autophagy induces dopaminergic neurodegeneration in rats","volume":"12","author":"Xilouri","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.autrev.2017.05.015_bb0545","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.4161\/auto.26451","article-title":"LAMP2A as a therapeutic target in Parkinson disease","volume":"9","author":"Xilouri","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.autrev.2017.05.015_bb0550","doi-asserted-by":"crossref","first-page":"13578","DOI":"10.1523\/JNEUROSCI.4390-09.2009","article-title":"Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases","volume":"29","author":"Spencer","year":"2009","journal-title":"J Neurosci"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2017.05.015_bb0555","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/jnc.13593","article-title":"Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance","volume":"139","author":"Hernandez","year":"2016","journal-title":"J Neurochem"},{"key":"10.1016\/j.autrev.2017.05.015_bb0560","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pneurobio.2011.08.008","article-title":"Autoimmune and inflammatory mechanisms of CNS damage","volume":"95","author":"Kapadia","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0565","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/09540261003589323","article-title":"The neuropsychiatry of multiple sclerosis: focus on disorders of mood, affect and behaviour","volume":"22","author":"Paparrigopoulos","year":"2010","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.autrev.2017.05.015_bb0570","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaut.2015.06.010","article-title":"The immunogenetics of multiple sclerosis: a comprehensive review","volume":"64","author":"Hollenbach","year":"2015","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.05.015_bb0575","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4161\/auto.5.2.7348","article-title":"Elevated ATG5 expression in autoimmune demyelination and multiple sclerosis","volume":"5","author":"Alirezaei","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.autrev.2017.05.015_bb0580","doi-asserted-by":"crossref","first-page":"26525","DOI":"10.1074\/jbc.M114.575860","article-title":"Deficiency of autophagy in dendritic cells protects against experimental autoimmune encephalomyelitis","volume":"289","author":"Bhattacharya","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2017.05.015_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2016.08.005","article-title":"Current trends in autoimmunity and the nervous system","author":"Selmi","year":"2016","journal-title":"J Autoimmun"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2017.05.015_bb0590","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ene.12883","article-title":"Disease-modifying treatments for multiple sclerosis - a review of approved medications","volume":"23","author":"Torkildsen","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0595","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1136\/bmj.2.5370.1436","article-title":"Multiple sclerosis: therpeutic trials of chloroquine, soluble aspirin, and gamma globulin","volume":"2","author":"Miller","year":"1963","journal-title":"Br Med J"},{"key":"10.1016\/j.autrev.2017.05.015_bb0600","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5607\/en.2016.25.5.233","article-title":"Astrocytes and microglia as non-cell autonomous players in the pathogenesis of ALS","volume":"25","author":"Lee","year":"2016","journal-title":"Exp Neurobiol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0605","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35097565","article-title":"From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS","volume":"2","author":"Cleveland","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.autrev.2017.05.015_bb0610","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.200908164","article-title":"Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond","volume":"187","author":"Ilieva","year":"2009","journal-title":"J Cell Biol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0615","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrneurol.2013.244","article-title":"Neurodegenerative disease: C9orf72 RNA foci\u2014a therapeutic target for ALS and FTD?","volume":"9","author":"Wood","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0620","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.celrep.2013.10.049","article-title":"Hexanucleotide repeats in ALS\/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic","volume":"5","author":"Lee","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.autrev.2017.05.015_bb0625","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.autrev.2017.05.015_bb0630","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","article-title":"Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis","volume":"79","author":"Ling","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.autrev.2017.05.015_bb0635","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.autrev.2017.05.015_bb0640","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0896-6273(00)80272-X","article-title":"ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions","volume":"18","author":"Bruijn","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.autrev.2017.05.015_bb0645","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1166066","article-title":"Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis","volume":"323","author":"Kwiatkowski","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.autrev.2017.05.015_bb0650","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.autrev.2017.05.015_bb0655","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/glia.22891","article-title":"NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients","volume":"63","author":"Johann","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.autrev.2017.05.015_bb0660","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fnins.2015.00400","article-title":"Golgi fragmentation in amyotrophic lateral sclerosis, an overview of possible triggers and consequences","volume":"9","author":"Sundaramoorthy","year":"2015","journal-title":"Front Neurosci"},{"key":"10.1016\/j.autrev.2017.05.015_bb0665","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/NEN.0b013e3182160690","article-title":"Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis","volume":"70","author":"Sasaki","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0670","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.jns.2015.08.254","article-title":"Autophagy dysregulation in amyotrophic lateral sclerosis","volume":"357","author":"Le","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2017.05.015_bb0675","doi-asserted-by":"crossref","first-page":"15030","DOI":"10.1038\/cddiscovery.2015.30","article-title":"ALS-associated mutant FUS inhibits macroautophagy which is restored by overexpression of Rab1","volume":"1","author":"Soo","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.autrev.2017.05.015_bb0680","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00401-015-1468-2","article-title":"Rab1-dependent ER-Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS","volume":"130","author":"Soo","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0685","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1093\/hmg\/ddu068","article-title":"C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking","volume":"23","author":"Farg","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.autrev.2017.05.015_bb0690","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nn.4012","article-title":"Exome sequencing uncovers hidden pathways in familial and sporadic ALS","volume":"18","author":"Bettencourt","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.autrev.2017.05.015_bb0695","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nchembio.1563","article-title":"Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models","volume":"10","author":"Barmada","year":"2014","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0700","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.4161\/auto.28784","article-title":"Pathogenic role of BECN1\/Beclin 1 in the development of amyotrophic lateral sclerosis","volume":"10","author":"Nassif","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.autrev.2017.05.015_bb0705","doi-asserted-by":"crossref","first-page":"498428","DOI":"10.1155\/2012\/498428","article-title":"Dysregulation of the autophagy-endolysosomal system in amyotrophic lateral sclerosis and related motor neuron diseases","volume":"2012","author":"Otomo","year":"2012","journal-title":"Neurol Res Int"},{"key":"10.1016\/j.autrev.2017.05.015_bb0710","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrn3430","article-title":"The changing scene of amyotrophic lateral sclerosis","volume":"14","author":"Robberecht","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.autrev.2017.05.015_bb0715","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.4161\/auto.25188","article-title":"Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons","volume":"9","author":"Castillo","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.autrev.2017.05.015_bb0720","first-page":"2517","article-title":"Role of autophagy in the pathogenesis of amyotrophic lateral sclerosis","volume":"2015","author":"Lee","year":"1852","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.autrev.2017.05.015_bb0725","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s12035-012-8371-9","article-title":"Expression of taurine transporter (TauT) is modulated by heat shock factor 1 (HSF1) in motor neurons of ALS","volume":"47","author":"Jung","year":"2013","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0730","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.2174\/0929867321666140706131825","article-title":"Therapeutic targeting of epigenetic components in amyotrophic lateral sclerosis (ALS)","volume":"21","author":"Lee","year":"2014","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.autrev.2017.05.015_bb0735","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mus.20076","article-title":"Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system","volume":"30","author":"Kieseier","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2017.05.015_bb0740","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.52.3.498","article-title":"Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy","volume":"52","author":"Bouchard","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2017.05.015_bb0745","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1085-9489.2006.00061.x","article-title":"Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"11","author":"Hughes","year":"2006","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.autrev.2017.05.015_bb0750","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1212\/01.wnl.0000188879.19900.b7","article-title":"Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP","volume":"65","author":"Sommer","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2017.05.015_bb0755","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/019131200750060023","article-title":"Chronic inflammatory demyelinating polyneuropathy: immunopathological and ultrastructural study of peripheral nerve biopsy in 42 cases","volume":"24","author":"Vital","year":"2000","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0760","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s004150200072","article-title":"Gamma delta T cells infiltrating sensory nerve biopsies from patients with inflammatory neuropathy","volume":"249","author":"Winer","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0765","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<474::AID-MUS8>3.0.CO;2-9","article-title":"Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy","volume":"19","author":"Schmidt","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2017.05.015_bb0770","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jneuroim.2004.10.021","article-title":"Gene expression profiling in chronic inflammatory demyelinating polyneuropathy","volume":"159","author":"Renaud","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0775","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.410300110","article-title":"Serum interleukin-2 concentrations in Guillain-Barr\u00e9 syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis","volume":"30","author":"Hartung","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0780","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1212\/WNL.56.5.666","article-title":"Serum levels of tumor necrosis factor-alpha in chronic inflammatory demyelinating polyneuropathy","volume":"56","author":"Misawa","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2017.05.015_bb0785","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1529-8027.2010.00294.x","article-title":"Distribution of Th17 cells and Th1 cells in peripheral blood and cerebrospinal fluid in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"15","author":"Chi","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.autrev.2017.05.015_bb0790","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/1531-8249(200006)47:6<765::AID-ANA9>3.0.CO;2-8","article-title":"Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients","volume":"47","author":"Yan","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0795","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/archneur.1980.00500590061010","article-title":"Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy","volume":"37","author":"Dalakas","year":"1980","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0800","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1085-9489.2005.0010207.x","article-title":"Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"10","author":"Allen","year":"2005","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.autrev.2017.05.015_bb0805","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/WNR.0000000000000543","article-title":"Autophagy is involved in the pathogenesis of experimental autoimmune neuritis in rats","volume":"27","author":"Zhou","year":"2016","journal-title":"Neuroreport"},{"key":"10.1016\/j.autrev.2017.05.015_bb0810","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"Bertsias","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.015_bb0815","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/0961203313512540","article-title":"Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE)","volume":"23","author":"Zirkzee","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.05.015_bb0820","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.015_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2016.06.013","article-title":"The diagnosis and clinical management of the neuropsychiatric manifestations of lupus","author":"Govoni","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.05.015_bb0830","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.autrev.2012.08.014","article-title":"Central nervous system involvement in systemic lupus erythematosus: overview on classification criteria","volume":"12","author":"Sciascia","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.015_bb0835","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jneuroim.2015.08.015","article-title":"TRPC6 gene variants and neuropsychiatric lupus","volume":"288","author":"Ramirez","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0840","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1136\/ard.2009.114157","article-title":"TREX1 gene variant in neuropsychiatric systemic lupus erythematosus","volume":"69","author":"de Vries","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.015_bb0845","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/gene.2010.73","article-title":"Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort","volume":"12","author":"Namjou","year":"2011","journal-title":"Genes Immun"},{"key":"10.1016\/j.autrev.2017.05.015_bb0850","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.autrev.2016.07.009","article-title":"The role of B cells and autoantibodies in neuropsychiatric lupus","volume":"15","author":"Wen","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.015_bb0855","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2015.10.003","article-title":"A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus","volume":"15","author":"Ho","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.015_bb0860","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrneurol.2014.148","article-title":"Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers","volume":"10","author":"Jeltsch-David","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0865","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-015-0269-8","article-title":"Neuropsychiatric lupus: a mosaic of clinical presentations","volume":"13","author":"Kivity","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.autrev.2017.05.015_bb0870","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrrheum.2014.15","article-title":"Diagnosis and management of neuropsychiatric SLE","volume":"10","author":"Hanly","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0875","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrrheum.2010.62","article-title":"Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations","volume":"6","author":"Bertsias","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0880","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ncprheum0726","article-title":"Neuropsychiatric systemic lupus erythematosus reconsidered","volume":"4","author":"S\u00e1nchez-Guerrero","year":"2008","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0885","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.autrev.2011.10.021","article-title":"Autoantibodies in lupus: culprits or passive bystanders?","volume":"11","author":"Rekvig","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.015_bb0890","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1096\/fj.11-194175","article-title":"Role of autophagy in immunity and autoimmunity, with a special focus on systemic lupus erythematosus","volume":"26","author":"Pierdominici","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.autrev.2017.05.015_bb0895","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4161\/auto.20275","article-title":"Macroautophagy is deregulated in murine and human lupus T lymphocytes","volume":"8","author":"Gros","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.autrev.2017.05.015_bb0900","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1096\/fj.12-206060","article-title":"T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy","volume":"26","author":"Alessandri","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.autrev.2017.05.015_bb0905","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/annrheumdis-2013-204343","article-title":"Autophagy is activated in systemic lupus erythematosus and required for plasmablast development","volume":"74","author":"Clarke","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.015_bb0910","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1136\/annrheumdis-2013-203794","article-title":"HRES-1\/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE","volume":"73","author":"Caza","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.015_bb0915","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/ard.2010.139832","article-title":"HSC70 blockade by the therapeutic peptide P140 affects autophagic processes and endogenous MHCII presentation in murine lupus","volume":"70","author":"Page","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.015_bb0920","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/15548627.2015.1017179","article-title":"Modulation of deregulated chaperone-mediated autophagy by a phosphopeptide","volume":"11","author":"Macri","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.autrev.2017.05.015_bb0925","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fimmu.2015.00252","article-title":"Manipulating autophagic processes in autoimmune diseases: a special focus on modulating chaperone-mediated autophagy, an emerging therapeutic target","volume":"6","author":"Wang","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0930","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001311","article-title":"Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes","volume":"7","author":"Taylor","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.autrev.2017.05.015_bb0935","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrg2571","article-title":"Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies","volume":"10","author":"Harley","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.autrev.2017.05.015_bb0940","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1136\/ard.2010.140111","article-title":"Genetic association of PRDM1-ATG5 intergenic region and autophagy with systemic lupus erythematosus in a Chinese population","volume":"70","author":"Zhou","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.015_bb0945","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/rheumatology\/ker263","article-title":"Replication of GWAS-identified systemic lupus erythematosus susceptibility genes affirms B-cell receptor pathway signalling and strengthens the role of IRF5 in disease susceptibility in a Northern European population","volume":"51","author":"J\u00e4rvinen","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2017.05.015_bb0950","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/BOR.0b013e328363eaf1","article-title":"Pathogenesis and treatment of CNS lupus","volume":"25","author":"Fanouriakis","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0955","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaut.2016.06.010","article-title":"Immunomodulators in SLE: clinical evidence and immunologic actions","volume":"74","author":"Durcan","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.05.015_bb0960","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/immu.200310002","article-title":"T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR\/lpr mice","volume":"33","author":"Monneaux","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2017.05.015_bb0965","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaut.2012.05.016","article-title":"Peptide-based approaches to treat lupus and other autoimmune diseases","volume":"39","author":"Schall","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.05.015_bb0970","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1002\/art.24027","article-title":"Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trial","volume":"58","author":"Muller","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.015_bb0975","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1136\/annrheumdis-2012-202460","article-title":"Lupuzor\/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial","volume":"72","author":"Zimmer","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.015_bb0980","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/0961203314525249","article-title":"The importance of implementing proper selection of excipients in lupus clinical trials","volume":"23","author":"Muller","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.05.015_bb0985","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/sj.cdd.4402312","article-title":"Apoptosis-linked changes in the phosphorylation status and subcellular localization of the spliceosomal autoantigen U1-70K","volume":"15","author":"Dieker","year":"2008","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.autrev.2017.05.015_bb0990","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005273","article-title":"The spliceosomal phosphopeptide P140 controls the lupus disease by interacting with the HSC70 protein and via a mechanism mediated by gammadelta T cells","volume":"4","author":"Page","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.05.015_bb0995","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/0961203314556138","article-title":"Resetting the autoreactive immune system with a therapeutic peptide in lupus","volume":"24","author":"Schall","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.05.015_bb1000","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1002\/art.20510","article-title":"Intramolecular T cell spreading in unprimed MRL\/lpr mice: importance of the U1-70k protein sequence 131-151","volume":"50","author":"Monneaux","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.015_bb1005","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.4049\/jimmunol.175.9.5839","article-title":"Selective modulation of CD4+ T cells from lupus patients by a promiscuous, protective peptide analog","volume":"175","author":"Monneaux","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.05.015_bb1010","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1186\/ar2317","article-title":"Importance of spliceosomal RNP1 motif for intermolecular T-B cell spreading and tolerance restoration in lupus","volume":"9","author":"Monneaux","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.05.015_bb1015","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.4161\/auto.26448","article-title":"HSPA8\/HSC70 chaperone protein: structure, function, and chemical targeting","volume":"9","author":"Stricher","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.autrev.2017.05.015_bb1020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.molimm.2015.04.007","article-title":"A central role for HSC70 in regulating antigen trafficking and MHC class II presentation","volume":"68","author":"Deffit","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2017.05.015_bb1025","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.immuni.2005.03.009","article-title":"Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens","volume":"22","author":"Zhou","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2017.05.015_bb1030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.immuni.2006.10.018","article-title":"Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes","volume":"26","author":"Schmid","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2017.05.015_bb1035","first-page":"3335","article-title":"Autophagy and its role in MHC-mediated antigen presentation","volume":"182","author":"Crotzer","year":"2009","journal-title":"J Immunol 1950"},{"key":"10.1016\/j.autrev.2017.05.015_bb1040","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev-immunol-032712-095910","article-title":"Pathways of antigen processing","volume":"31","author":"Blum","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2017.05.015_bb1045","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nri3532","article-title":"Autophagy in infection, inflammation and immunity","volume":"13","author":"Deretic","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2017.05.015_bb1050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.coi.2014.12.006","article-title":"Modulation of antigen presentation by intracellular trafficking","volume":"34","author":"Mintern","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2017.05.015_bb1055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(10)70224-6","article-title":"Energy metabolism in amyotrophic lateral sclerosis","volume":"10","author":"Dupuis","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2017.05.015_bb1060","doi-asserted-by":"crossref","first-page":"18171","DOI":"10.1073\/pnas.0405831102","article-title":"Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease","volume":"101","author":"Maswood","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2017.05.015_bb1065","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.nbd.2006.12.019","article-title":"Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease","volume":"26","author":"Halagappa","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.autrev.2017.05.015_bb1070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1385\/NMM:9:1:17","article-title":"Energy intake and amyotrophic lateral sclerosis","volume":"9","author":"Mattson","year":"2007","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.autrev.2017.05.015_bb1075","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0140-6736(14)60222-1","article-title":"Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial","volume":"383","author":"Wills","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2017.05.015_bb1080","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1021\/bc100039u","article-title":"Thiopalmitoylated peptides from the peripheral nervous system myelin p0 protein: synthesis, characterization, and neuritogenic properties","volume":"21","author":"Beaino","year":"2010","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.autrev.2017.05.015_bb1085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2014.11.022","article-title":"Characterization of a new rat model for chronic inflammatory demyelinating polyneuropathies","volume":"278","author":"Brun","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2017.05.015_bb1090","doi-asserted-by":"crossref","first-page":"6907","DOI":"10.4049\/jimmunol.166.11.6907","article-title":"Thiopalmitoylation of myelin proteolipid protein epitopes enhances immunogenicity and encephalitogenicity","volume":"166","author":"Greer","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.05.015_bb1095","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.4049\/jimmunol.180.3.1398","article-title":"Route of uptake of palmitoylated encephalitogenic peptides of myelin proteolipid protein by antigen-presenting cells: importance of the type of bond between lipid chain and peptide and relevance to autoimmunity","volume":"180","author":"Pfender","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.05.015_bb1100","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1474-4422(10)70041-7","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition","volume":"9","author":"Vallat","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2017.05.015_bb1105","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.autrev.2014.08.015","article-title":"Neuropsychiatric systemic lupus erythematosus and cognitive dysfunction: the MRL-lpr mouse strain as a model","volume":"13","author":"Jeltsch-David","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.015_bb1110","series-title":"Psychoneuroimmunology: Methods and Protocols","first-page":"277","article-title":"Model: an invaluable tool in studies of autoimmunity\u2013brain interactions","author":"Saki\u0107","year":"2012"},{"key":"10.1016\/j.autrev.2017.05.015_bb1115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaut.2016.04.005","article-title":"Autoimmunity, neuroinflammation, pathogen load: a decisive crosstalk in neuropsychiatric SLE","volume":"74","author":"Jeltsch-David","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.05.015_bb1120","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1177\/0961203315593817","article-title":"Symptoms of attention deficit hyperactivity disorder in patients with systemic lupus erythematosus","volume":"24","author":"Gao","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.05.015_bb1125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.clinimag.2004.07.007","article-title":"Neuropsychiatric systemic lupus erythematosus: correlation of brain MR imaging, CT, and SPECT","volume":"29","author":"Abreu","year":"2005","journal-title":"Clin Imaging"},{"key":"10.1016\/j.autrev.2017.05.015_bb1130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1749-6632.2011.06076.x","article-title":"PET\/CT imaging in systemic lupus erythematosus","volume":"1228","author":"Curiel","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2017.05.015_bb1135","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.autrev.2013.07.004","article-title":"Neuropsychiatric systemic lupus erythematosus: magnetic resonance imaging findings and correlation with clinical and immunological features","volume":"12","author":"Toledano","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.05.015_bb1140","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1136\/ard.2005.049486","article-title":"Hippocampal atrophy in systemic lupus erythematosus","volume":"65","author":"Appenzeller","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.015_bb1145","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0961203313511556","article-title":"In vivo evaluation of brain damage in the course of systemic lupus erythematosus using magnetic resonance spectroscopy, perfusion-weighted and diffusion-tensor imaging","volume":"23","author":"Zimny","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.05.015_bb1150","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.semarthrit.2011.11.010","article-title":"A prospective functional MRI study for executive function in patients with systemic lupus erythematosus without neuropsychiatric symptoms","volume":"41","author":"Mak","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.015_bb1155","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1002\/art.21271","article-title":"Cerebral and corpus callosum atrophy in systemic lupus erythematosus","volume":"52","author":"Appenzeller","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.015_bb1160","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/art.23452","volume":"58","author":"Emmer","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.015_bb1165","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1002\/art.27717","article-title":"Tract-based spatial statistics on diffusion tensor imaging in systemic lupus erythematosus reveals localized involvement of white matter tracts","volume":"62","author":"Emmer","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.015_bb1170","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1177\/0961203312459104","article-title":"The efficacy of brain (18)F-fluorodeoxyglucose positron emission tomography in neuropsychiatric lupus patients with normal brain magnetic resonance imaging findings","volume":"21","author":"Lee","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2017.05.015_bb1175","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/rheumatology\/kel255","article-title":"Voxel-based morphometry of brain SPECT can detect the presence of active central nervous system involvement in systemic lupus erythematosus","volume":"46","author":"Appenzeller","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2017.05.015_bb1180","first-page":"194","article-title":"Neuropsychiatric lupus: clinical and imaging aspects","volume":"65","author":"Brey","year":"2007","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"10.1016\/j.autrev.2017.05.015_bb1185","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1471-4159.2009.06319.x","article-title":"The blood-brain barrier in neurodegenerative disease: a rhetorical perspective","volume":"111","author":"Carvey","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.autrev.2017.05.015_bb1190","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nri2529","article-title":"Losing your nerves? Maybe it's the antibodies","volume":"9","author":"Diamond","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2017.05.015_bb1195","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and dysfunction of the blood-brain barrier","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2017.05.015_bb1200","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3390\/ph7121028","article-title":"Role of microglial m1\/m2 polarization in relapse and remission of psychiatric disorders and diseases","volume":"7","author":"Nakagawa","year":"2014","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.autrev.2017.05.015_bb1205","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.it.2015.08.003","article-title":"Microglia plasticity during health and disease: an immunological perspective","volume":"36","author":"Shemer","year":"2015","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2017.05.015_bb1210","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nn.4184","article-title":"Glia as drivers of abnormal neuronal activity","volume":"19","author":"Robel","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.autrev.2017.05.015_bb1215","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1084\/jem.20132477","article-title":"Differential roles of microglia and monocytes in the inflamed central nervous system","volume":"211","author":"Yamasaki","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.05.015_bb1220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2014.07.012","article-title":"Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases","volume":"274","author":"Gonz\u00e1lez","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2017.05.015_bb1225","doi-asserted-by":"crossref","first-page":"381","DOI":"10.14348\/molcells.2015.0034","article-title":"Autophagy in neurodegenerative diseases: from mechanism to therapeutic approach","volume":"38","author":"Nah","year":"2015","journal-title":"Mol Cells"},{"key":"10.1016\/j.autrev.2017.05.015_bb1230","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1084\/jem.20150956","article-title":"Therapeutic targeting of autophagy in neurodegenerative and infectious diseases","volume":"212","author":"Rubinsztein","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.05.015_bb1235","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s12035-014-8933-0","article-title":"Crosstalk between macroautophagy and chaperone-mediated autophagy: implications for the treatment of neurological diseases","volume":"52","author":"Wu","year":"2015","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.autrev.2017.05.015_bb1240","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nri.2016.100","article-title":"Crosstalk between autophagy and inflammatory signalling pathways: balancing defence and homeostasis","volume":"16","author":"Cadwell","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2017.05.015_bb1245","doi-asserted-by":"crossref","first-page":"526","DOI":"10.15252\/emmm.201404433","article-title":"A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Palamiuc","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.autrev.2017.05.015_bb1250","doi-asserted-by":"crossref","first-page":"13138","DOI":"10.1523\/JNEUROSCI.4790-12.2013","article-title":"Arctigenin effectively ameliorates memory impairment in Alzheimer's disease model mice targeting both \u03b2-amyloid production and clearance","volume":"33","author":"Zhu","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2017.05.015_bb1255","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00394-015-0894-1","article-title":"Resveratrol reduces amyloid-beta (A\u03b2\u2081\u208b\u2084\u2082)-induced paralysis through targeting proteostasis in an Alzheimer model of Caenorhabditis elegans","volume":"55","author":"Regitz","year":"2016","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.autrev.2017.05.015_bb1260","article-title":"Triptolide inhibited cytotoxicity of differentiated PC12 cells induced by amyloid-Beta\u2082\u2085\u208b\u2083\u2085 via the autophagy pathway","volume":"10","author":"Xu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.05.015_bb1265","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejphar.2014.06.051","article-title":"Downregulation of PI3K\/Akt\/mTOR signaling pathway in curcumin-induced autophagy in APP\/PS1 double transgenic mice","volume":"740","author":"Wang","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.autrev.2017.05.015_bb1270","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4161\/auto.8.1.18313","article-title":"Isorhynchophylline, a natural alkaloid, promotes the degradation of alpha-synuclein in neuronal cells via inducing autophagy","volume":"8","author":"Lu","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.autrev.2017.05.015_bb1275","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1007\/s12035-015-9173-7","article-title":"Treatment with trehalose prevents behavioral and neurochemical deficits produced in an AAV \u03b1-Synuclein rat model of Parkinson's disease","volume":"53","author":"He","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.autrev.2017.05.015_bb1280","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3390\/ijms15011625","article-title":"Resveratrol partially prevents rotenone-induced neurotoxicity in dopaminergic SH-SY5Y cells through induction of heme oxygenase-1 dependent autophagy","volume":"15","author":"Lin","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2017.05.015_bb1285","doi-asserted-by":"crossref","first-page":"22618","DOI":"10.3390\/ijms141122618","article-title":"Onjisaponin B derived from Radix Polygalae enhances autophagy and accelerates the degradation of mutant \u03b1-synuclein and huntingtin in PC-12 cells","volume":"14","author":"Wu","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2017.05.015_bb1290","doi-asserted-by":"crossref","first-page":"22693","DOI":"10.1074\/jbc.M113.477505","article-title":"Epigallocatechin gallate (EGCG) stimulates autophagy in vascular endothelial cells: a potential role for reducing lipid accumulation","volume":"288","author":"Kim","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2017.05.015_bb1295","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.18632\/oncotarget.3832","article-title":"EGCG-mediated autophagy flux has a neuroprotection effect via a class III histone deacetylase in primary neuron cells","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.autrev.2017.05.015_bb1300","doi-asserted-by":"crossref","first-page":"15270","DOI":"10.1038\/srep15270","article-title":"EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism","volume":"5","author":"Modernelli","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2017.05.015_bb1305","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.bbrc.2013.07.097","article-title":"Epigallocatechin-gallate (EGCG) regulates autophagy in human retinal pigment epithelial cells: a potential role for reducing UVB light-induced retinal damage","volume":"438","author":"Li","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2017.05.015_bb1310","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/hmg\/ddl210","article-title":"Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models","volume":"15","author":"Ehrnhoefer","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.autrev.2017.05.015_bb1315","article-title":"Therapeutic effect of berberine on Huntington's disease transgenic mouse model","volume":"10","author":"Jiang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.05.015_bb1320","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuroscience.2015.03.061","article-title":"Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model","volume":"298","author":"Li","year":"2015","journal-title":"Neuroscience"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T10:45:30Z","timestamp":1657795530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997217301398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":264,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1568997217301398"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.05.015","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autophagy in neuroinflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}